Abbreviations: AST, aspartate aminotransferase; AUC, area under the plasma concentration-time curve, BBB, blood-brain barrier; ‫ܥ‬ ଷ , brain concentration at 30 min;
Introduction
Partial hepatectomy (Hx) or liver resection is usually used for living donor liver transplantation and treatment of various liver diseases such as benign and malignant tumors. Due to the unique anatomical structure and function of the liver, hepatic surgery, including liver resection, is associated with a significant degree of risk (Huntington et al., 2014; Savage and Malt, 1991) , including excessive bleeding. Pringle maneuver, developed by J. H. Pringle in 1908, is one of the major strategies to reduce excessive bleeding by completely occluding blood supply to the liver (Huntington et al., 2014; Yang et al., 2014) . However, the resultant ischemia and subsequent reperfusion produces a series of events, leading to the so-called ischemia-reperfusion (IR) injury.
One of the hallmarks of the liver IR injury is activation of Kupffer cells mediated by the release of gastrointestinal lipopolysaccharides (LPS), which leads to the synthesis and release of reactive oxygen species and pro-inflammatory mediators, such as tumor necrosis factor-α, interleukin-1β, and interleukin-6 (Jaeschke and Farhood, 1991; Liu et al., 1995; Wanner et al., 1996) .
Additionally, these pro-inflammatory mediators alter the expression and function of different drug transporters in the liver (Ikemura et al., 2009; Miah et al., 2014; Parasrampuria et al., 2012; Tanaka et al., 2006) , as well as in the remote organs such as intestine (Ikemura et al., 2009 ) and kidneys (Tanaka et al., 2008) . Therefore, Hx and/or Pringle maneuver could potentially alter the disposition of xenobiotics and endogenous compounds in patients who are subjected to these procedures.
Very recently (Miah et al., 2014) , we demonstrated that the hepatic IR injury alters the expression and function of P-glycoprotein (P-gp) in the liver canalicular membranes as well as in the brain. Additionally, liver diseases are associated with increased plasma bile acids and ammonia (Tanaka et al., 2006; Wright et al., 2014) , both of which have shown to increase the BBB permeability (Quinn et al., 2014; Skowronska et al., 2012) . A potential increase in the BBB permeability could lead to increased passage of neurotoxins into the brain, which may be responsible for different neurological complications that are associated with hepatic diseases (Leke et al., 2013) . However, the effects of hepatic IR and/or partial hepatectomy on the integrity of the BBB and its paracellular permeability to xenobiotics and endogenous compounds have not yet been studied.
Sodium fluorescein (FL) is a hydrophilic, low molecular weight (376 Da) dye, which cannot cross BBB transcellularly. Therefore, it can enter the brain through paracellular route, which is very limited in normal brain due to the BBB tight junctions. Because of these characteristics, FL has been used extensively as an in vivo marker to determine the changes in the paracellular permeability of BBB in different diseases (Kaya and Ahishali, 2011) . In most experiments, investigators use the absolute brain concentrations of FL as a measure of BBB permeability (Cao et al., 2015; Nishioku et al., 2010; Oppenheim et al., 2013; Tress et al., 2014) .
However, this approach may result in inaccuracies if the systemic exposure of the marker, such as area under the plasma concentration-time curve (AUC), is also altered by the disease or the intervention. Furthermore, previous studies have shown that a significant fraction of FL circulating in the plasma is bound to plasma proteins (Li and Rockey, 1982) . Because only the free drug is expected to cross the membranes, including the BBB, a change in the free fraction of FL in plasma may also affect the degree of accumulation of the marker in the brain (Mandula et al., 2006) . Therefore, the use of brain concentrations of FL alone, or even after its correction for the total (free plus bound) plasma concentrations of FL, may be a misleading indication of the BBB permeability when the plasma exposure and/or free fraction of the marker in plasma is altered.
Our main goal for the current study was to investigate the effects of hepatic IR (Pringle maneuver) alone or in combination with Hx (HxIR) on the paracellular blood-brain barrier (BBB) permeability using FL as a marker. Our hypothesis was that hepatic IR with or without Hx would increase the BBB permeability to FL. Additionally, because FL is both metabolized by the liver and excreted into the bile (Webb et al., 1962) , we were interested in investigating the effects of IR and/or HxIR on the hepatobiliary disposition and systemic pharmacokinetics of the marker. Our studies show whereas Hx and HxIR significantly alter the hepatobiliary disposition, plasma free fraction, and absolute brain concentrations of FL, BBB permeability to FL corrected based on the systemic pharmacokinetics of the marker remains unchanged by these surgical interventions.
Results

Plasma concentrations of biochemical markers
The plasma concentrations of aspartate aminotransferase (AST), total bile acids (TBA), and albumin in both the 15-Min and 8-h groups are presented in Fig. 1 . The plasma concentrations of the liver injury marker AST in the HxIR groups were significantly higher than those in their corresponding Sham groups in both 15-Min (p < 0.05) and 8-h (p < 0.001) reperfusion groups ( Fig. 1a and 1b) . However, the AST concentrations in the IR groups were significantly (p < 0.001) higher from those in the Sham group only in the 15-Min group (Fig. 1a and 1b) . Although the TBA concentrations in the 15-Min IR and HxIR groups were higher than those in the corresponding Sham groups, only the difference between the IR and Sham groups were statistically significant (p < 0.01) at this time point (Fig. 1c) . On the other hand, at 8 h post reperfusion, the TBA concentrations in the HxIR group, and not in the IR group, were significantly (p < 0.0001) higher than those in the corresponding Sham group (Fig. 1d) . As for the plasma albumin concentrations, there were no significant differences among the surgical groups at either reperfusion time points (Figs. 1e and 1f ).
Plasma pharmacokinetics of FL
The plasma concentration-time courses of FL in different surgical groups after 15 min or 8 h of reperfusion are depicted in Fig. 2 , and the corresponding AUC and free fraction in plasma (f u ) values are presented in Table 1 . The plasma concentrations in the IR and HxIR groups were generally higher than those in the Sham groups (Fig. 2) . However, only the AUC values for the 15-Min HxIR (p < 0.05) and 8-h IR (p < 0.01) groups were significantly higher than those of their corresponding Sham groups (Table 1) . Additionally, the f u values of FL in the HxIR groups were higher (p < 0.01) than those in their respective Sham groups for both the 15-Min and 8-h groups (Table 1) .
Biliary excretion of FL and FL-Glu
The bile data for FL and its glucuronidated metabolite, FL-Glu, are presented in Figs. 3 and 4 for the 15-Min and 8-h reperfusion groups, respectively. For the 15-Min reperfusion groups (Fig. 3) , IR and HxIR, respectively, caused 74% and 89% reductions (p < 0.0001) in the biliary recovery of FL (Fig. 3a) , which was also reflected in its Cl bile,app (Fig. 3b) . Similar patterns were also noted for the biliary recovery of FL-Glu (Fig. 3c ) and the total biliary recoveries of FL plus FLGlu (Fig. 3d) . Additionally, the bile flow rates in the IR and HxIR groups were, respectively, 61% and 73% lower (p < 0.0001) than those in the Sham group (Fig. 3e) . In fact, there were significant correlations (p < 0.0001) between the biliary recovery of FL or FL-Glu and the bile flow rate with r 2 values of 0.929 or 0.938, respectively (Fig. 3f) .
After 8 h of reperfusion (Fig. 4) , the bile flow rates and biliary recoveries of FL and/or FL-Glu for the IR group returned to values not significantly different from those in the Sham animals. However, the corresponding values for the HxIR animals remained significantly lower than those in the Sham animals even after 8 h of reperfusion (Fig. 4) . Similar to the 15-Min reperfusion groups, the correlation between the biliary recoveries of FL or FL-Glu and bile flow rate remained significant (p < 0.0001) for the 8-h groups (Fig. 4f) . Figure 5 depicts the representative Western blots (a and b) and individual densitometric data for Mrp2 (c and d) and Oatp1a4 (e and f) levels in the liver membrane fractions. The protein levels of Mrp2 in the IR and HxIR groups after 15 min of reperfusion were significantly higher than those in their corresponding Sham livers (Fig. 5c ). However, there were no differences among the surgical groups for Mrp2 levels in the 8-h reperfusion groups (Fig. 5d) . Additionally, the protein levels of Oatp1a4 were similar in all the surgical groups after 15 min (Fig. 5e ) or 8 h ( Fig. 5f ) of reperfusion.
Western blot analysis of liver transporters
Liver concentrations of ATP
The concentrations (µmol/g tissue) of ATP in the right lobes of the livers in the IR group after 15 min of reperfusion (0.723 ± 0.414) were 65% lower (p < 0.01, unpaired t-test) than those in the 8 h IR group (2.08 ± 0.447).
Brain uptake of FL
The brain concentrations and apparent uptake clearance (K in ) values of FL, based on both the total (free plus bound) and free (unbound) concentrations of FL in plasma, are presented in Fig.   6 . The brain concentrations of FL in the IR and HxIR were between 1.8 to 2.0 fold higher than those in their corresponding Sham animals after both 15 min ( Fig. 6a ) and 8 h (Fig. 6b) 
Discussion
Recent studies (Hashimoto and Sanjo, 1997; Ikemura et al., 2009; Parasrampuria et al., 2012; Shaik and Mehvar, 2011; Thorling et al., 2014; Tian et al., 2005a; Tian et al., 2005b) have shown that IR injury or Hx alters the disposition of drugs. In agreement with these studies, our current investigation showed that IR alone or in combination with Hx (HxIR) would change the systemic pharmacokinetics of FL (Table 1 and It has been reported (Pardridge and Landaw, 1984; Tanaka and Mizojiri, 1999 ) that for some drugs the free fraction of the drug in the blood could not adequately explain their in vivo brain uptake. Therefore, it was suggested that an interaction between the plasma proteins and the brain capillary membranes would result in conformational changes in the proteins, resulting in enhanced dissociation of some drugs from the proteins and increased brain uptake. However, it was later suggested (Mandula et al., 2006 ) that the reported apparent enhanced dissociation effect might have been related to the mixing of the bolus dose solutions, containing different concentrations of proteins, with the circulating blood passing through the brain vasculature.
Nevertheless, the BBB permeability of FL is very low, compared with the cerebral blood flow, suggesting that the K in value of FL is directly proportional to its f u and free permeability-surface area product. Collectively, our data suggest that when FL is used as an in vivo BBB permeability marker, one has to consider the potential changes in both the systemic exposure (AUC) and degree of protein binding of the marker in plasma, in addition to its brain accumulation.
The increases in the f u of FL, observed in the HxIR rats (Table 1) , potentially could be due to a decrease in the concentrations of serum albumin and/or a decrease in the binding affinity of the marker to albumin. Because the plasma albumin concentrations were not altered in any of the surgical groups (Figs. 1e and 1f), HxIR most likely resulted in a decrease in the affinity of FL binding to albumin. Fluorescein is a weakly acidic drug, which is bound mainly to albumin in the plasma (Manzini and Crescenzi, 1979) . Our recent in vitro studies (Shaik et al., 2013) showed that the f u of FL increases with an increase in the concentrations of bile acids, such as lithocholic acid, cholic acid, chenodeoxycholic acid, and taurocholic acid, which are also bound to albumin (Roda et al., 1982) . Therefore, the increases in the concentrations of plasma TBA in the IR and 3 ) and 8 h (Fig. 4) , the reductions in the IR groups were present only after 15 min of reperfusion ( Indeed, the return of the biliary excretion of FL (Fig. 4a ) and FL-Glu (Fig. 4c) to normal values at 8 h after the reperfusion in the IR group is in agreement with the return of the plasma TBA (Fig. 1d ) and the liver injury marker AST to normal values in this group (Fig. 1) .
To further explore the potential mechanisms of time-dependent changes in the biliary excretions of FL and FL-Glu in the IR animals, we investigated the effects of surgical procedures on the liver transporters responsible for the uptake and biliary excretion of FL and FL-Glu. In the liver, FL reportedly enters the hepatocytes via human OATP1B (De Bruyn et al., 2011) , which is similar to rat Oatp1a4. Once inside the hepatocyte, FL is metabolized to FL-Glu, and both the marker and its glucuronidated metabolite are excreted into the bile through the Mrp2 transporter (Mills et al., 1999; Thorling et al., 2013) . The observed lack of change in the liver membrane Oatp1a4 protein as a result of IR or HxIR (Figs. 5e and 5f) suggests that the uptake of FL into the liver is not compromised in these surgical groups. However, the Mrp2 protein levels in the liver membranes were significantly increased in both surgical groups after 15 min of reperfusion (Figs. 5c and 5d). The increased Mrp2 levels at 15 min reperfusion time are in an opposite direction to the reductions in the biliary excretion of FL and FL-Glu in these animals (Figs. 3a-3d ). However, the function of ATP-binding cassette transporters, such as Mrp2, is rate-limited by the availability of tissue ATP, which is substantially compromised by the IR injury (Bedirli et al., 2008) . Therefore, the decreases in the biliary excretion of the marker and its metabolite in the 15 min IR animals ( Figs. 3a and 3c) , which return to normal values after 8 h of reperfusion (Figs. 4a and 4c), could be due to lower hepatic concentrations of ATP early after reperfusion, followed by its recovery at the 8 h reperfusion time. To test this postulate, we conducted an additional study using two IR groups at 15 min and 8 h of reperfusion (n = 4/group) to specifically collect and store the liver tissues for ATP measurements, which require strict handling and storage.
Indeed, the ATP levels in the 15 min IR group were 65% lower than those with the 8 h of reperfusion, indicating that the low biliary excretions of FL and FL-Glu in the 15 min IR groups, which was not observed in the 8 h IR animals, are most likely due to lower ATP levels in these animals.
The IR-induced lower biliary excretion of FL and FL-Glu, despite an overexpression of the responsible transporter (Mrp2), is in agreement with our previous study (Miah et al., 2014) using rhodamine 123, which is excreted into the bile by P-glycoprotein (P-gp). Whereas P-gp levels were overexpressed 24 h after 90 min of partial ischemia, the biliary excretion of rhodamine 123 was significantly reduced because of a significant reduction in the liver ATP concentrations. Although the ischemia model used in our current study (total ischemia for 20 min) is different from the reported model (90 min of partial ischemia), our data confirms the importance of the liver ATP concentrations in the biliary excretion of drugs by the ATP-binding cassette transporters.
Previous studies by us and others using partial (70%) hepatic IR model with 60-90 min of ischemia have shown a significant reduction in the mRNA (Tanaka et al., 2006) and protein (Miah et al., 2014; Tanaka et al., 2008) levels of Mrp2 at 24 h of reperfusion, without any significant changes at 3 or 6 h of reperfusion. The increased protein level of Mrp2 in our studies at much earlier reperfusion time (15 min) does not contradict these data. This is because the effects of IR on the protein levels of Mrp2 are most likely time dependent, and a later (24 h reperfusion) downregulation does not preclude a much earlier (15 min reperfusion) increased levels of Mrp2. Additionally, the effects of 60-90 min of partial (70%) ischemia on the expression of Mrp2, reported in the literature, might be different from those in a 20-min Pringle maneuver (complete ischemia), used in our current study. Nevertheless, the increased protein levels of Mrp2 in the liver membranes observed early after reperfusion (15 min) in our studies might be due to changes in the trafficking of the transporter between the canalicular membranes and cytoplasm, as reported before (Ban et al., 2009) , rather than an increased expression of the transporter.
The substantial decreases in the biliary excretions of FL and FL-Glu in the IR and HxIR animals, observed in our study, were associated with significant decreases in the bile flow rates (Figs. 3e, 3f , 4e, and 4f). The decreases in the bile flow rates of the HxIR animals at both 15 min ( Fig. 3e ) and 8 h (Fig.4e) are consistent with the substantial loss of liver mass in these animals.
However, the lower bile flow rates in the IR animals, observed only after 15 min (Fig. 3e ) and not after 8 h (Fig. 4e) Another widely-used, low MW BBB permeability marker is 14 C-sucrose, which is not bound to plasma proteins. Therefore, in contrast to FL, the use of 14 C-sucrose is not complicated by the requirement for measurement of the free plasma concentration of the marker. However, similar to our studies with FL reported here, accurate measurement of the BBB permeability using 14 C-sucrose also requires estimation of K in values using the terminal brain concentration and the plasma AUC (Bickel, 2005; Ohno et al., 1978) . Although 14 C-sucrose is considered the gold standard for the measurement of the BBB permeability through tight junctions (Ohno et al., 1978) , its use is limited to laboratories that can handle radioactive materials. Therefore, FL is still used by many investigators because of its ease of handling and detection. Our data, however, clearly show that the appropriate use of FL requires an additional step to measure the free drug concentration in plasma.
In conclusion, Pringle maneuver with or without partial hepatectomy caused decreases in the biliary excretion and increases in the plasma free fraction, AUC, and the brain concentrations of the BBB permeability marker FL. However, the increased brain concentrations of FL in IR and HxIR were due to the changes in the plasma AUC and free fraction of the marker. Therefore, when the brain concentrations of FL were corrected for the changes in its systemic pharmacokinetics, the surgical procedures did not have any impact on the BBB permeability to FL. These studies indicate that accurate estimation of BBB permeability using FL requires consideration of both brain and systemic pharmacokinetics, including degree of plasma protein binding, of the marker.
Experimental Procedures
Chemicals and reagents
Sodium fluorescein (FL) and β-glucuronidase (Type-LII) were obtained from Sigma-Aldrich (St. Anaheim, CA, USA), total bile acids (TBA) (Crystal Chem; Downers Grove, IL), and albumin (Active Motif; Carlsbad, CA) were purchased from commercial sources. BCA kit for the measurement of protein was purchased from Pierce Biotechnology (Rockford, IL, USA). All other chemicals were analytical grade and commercially available.
Animals
Our Institutional Animal Care and Use Committee approved the use of animals in the study.
Additionally, all the procedures involving animals used in this study were consistent with the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) . Adult, male Sprague-Dawley rats were purchased from Charles River Laboratories (Wilmington, MA) and were acclimated with 12-h dark-light cycle in a temperature-and humidity-controlled room before surgery. Animals had free access to food and water before the experiments.
Ischemia-reperfusion and partial hepatectomy models
Animals (body weight: 240-300 g) were subjected to sham (Sham), hepatic ischemia-reperfusion (IR), or IR plus partial hepatectomy (HxIR) surgery. After an overnight fast, rats were anesthetized with an intramuscular injection of ketamine: xylazine (80:8 mg/kg), and the abdomen was opened using a midline incision. For the IR group, the total blood supply to the liver was occluded by placing a microvascular surgical clamp on the portal triad (portal vein, hepatic artery, and bile duct). After 20 min of ischemia, the clamp was removed to allow reperfusion of the ischemic liver with blood. In the HxIR group, immediately after the interruption of the blood supply with the clamp, partial (70%) hepatectomy of the liver was performed by ligating and excising the left and median lobes of the liver at their base, as described before (Emond et al., 1989) . Similar to the IR group, after 20 min of ischemia, blood supply to the HxIR livers was reinstated by removing the clamp. Sham animals underwent only laparotomy and manipulation of the liver and blood vessels, without any interruption in the blood supply to the liver. During the surgery, rat body temperature was closely monitored and maintained at 37ᴼC by using a combination of a heat lamp and a heating plate attached to a rectal temperature control probe.
Dosing and sampling
Three surgical groups of Sham, IR, and HxIR each with two reperfusion times of 15 min or 8 h were used in this study, resulting in a total of six experimental groups with 6-7 animals/group.
To collect blood and bile samples, catheters were placed into the femoral artery and bile duct of the anesthetized animals, respectively. FL was then infused into the penile vein of the animals at a dose of 25 mg/kg (acid equivalent) over 5 min. Blood samples were collected at 0, 5, 10, 20, and 30 min. Each time after collection of blood samples, catheter was filled with heparin (10 U/ml) to prevent the formation of blood clot. Immediately after the collection of blood, plasma was separated by centrifugation for 5 min at 14000 rpm. At the end of experiments, the whole rat body was perfused, through a catheter inserted into the left ventricle, with an ice-cold saline solution at the rate of 25 ml/min for three min to remove the residual blood from the brain.
Finally, brain samples were collected and snap frozen in isopentane (-80 o C). All the samples were kept at -80ᴼC until analysis.
Analysis of fluorescein in plasma, brain, and bile samples
Concentrations of FL in the biological samples were determined by minor modifications of a previously published paper (Selan et al., 1985) , as described in detail recently (Shaik et al., 2013) . Brain samples were homogenized in de-ionized water (1:4) using an electric homogenizer. All the other samples were diluted with a 4% bovine serum albumin (BSA) solution in water before being subjected to the sample preparation method (Shaik et al., 2013) .
The plasma samples were diluted 100 fold. Additionally, the terminal plasma samples (30 min)
were also subjected to ultrafiltration using Microcon Ultracel YM-30 centrifugal devices, as described in detail before, (Shaik et al., 2013) and were diluted 50 fold. Diluted (1000 fold) bile samples were analyzed twice in the absence or presence of β-glucuronidase, as described in detail before (Shaik et al., 2013 ).
Quantitation of plasma biochemical markers
The plasma concentrations of AST, TBA, and albumin were measured using commercially available kits, following the manufacturers' protocols.
Quantitation of liver ATP
ATP concentrations in the samples from the right lobe of the livers were measured using a reversed-phase, gradient HPLC method (Manfredi et al., 2002) .
Western blot analysis
The protein contents of Mrp2, Oatp1a4, and the loading control β-actin were determined in crude membrane fractions of the liver, which were prepared according to standard methods. Briefly, liver tissues were homogenized in tissue homogenization buffer (1:4), containing 10 mM TrisHCl (pH 7.4), 1 mM mercaptoethanol, 1 mM ethylene glycol tetraacetic acid, 1 mM MgCl 2 , 1 mM DL-dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, and 1% glycerol. To 1 ml of the homogenate were added 40 µl of 0.5 M Tris-HCl and 1 µl of protease inhibitor cocktail for mammalian tissue extracts (Sigma). The homogenate was then centrifuged at 2000 g for 15 min (4ᴼC); supernatant was isolated and centrifuged again at 100,000 g for 30 min (4ᴼC); and the resultant pellet was re-suspended in 250 µl of homogenization buffer, containing 2.5 µl of the protease inhibitor phenylmethylsulfonyl fluoride (100 mM). Protein concentrations in the samples were measured by the BCA kit. Finally, 40 µg of liver proteins were electrophoretically resolved using 4-20% gradient SDS-polyacrylamide gels (Thermo Scientific, Rockford, IL, USA), and the resolved proteins were transferred onto a polyvinylidene difluoride membrane.
The membranes were blocked for 1 h at room temperature with 5% nonfat instant milk, followed by overnight incubation (4ᴼC) with primary antibodies anti-Mrp2 (1:1000), anti-Oatp1a4
(1:1000), and anti-β-actin. After washing, the membranes were incubated with secondary antibodies for 1 h, and band intensities were quantified using VersaDoc Image system and Quantity One software (Bio-Rad, Hercules, CA, USA).
Pharmacokinetic analysis
Linear trapezoidal method was used to calculate the AUC of FL from zero to 30 min ‫ܥܷܣ(‬ ିଷ ).
As a measure of the BBB permeability, apparent brain uptake clearance ‫ܭ(‬ ) of FL was determined by using the following equations (Bickel, 2005) :
where ‫ܥ‬ 
Statistical analysis
All the results are presented as mean ± SD. The statistical differences among the surgical groups were analyzed using one-way ANOVA, followed by 
